nonyabizznez
Registered
I think they released vials in the US in part to negate any compounding argument for odd dosages. Now if a patient says they can't tolerate 5mg and need 4mg it can happen. Takes the legs off one of the compounders main arguments. Some telehealth anticipated this from the beginning... I know Henry Meds initial dosage schedule didn't align with Lilly's and several telehealth offered unique dosages the moment Tirz came off the shortage list in the fall.Lilly expanding their cash for vials program does provide an off ramp for many that were paying for compound. It is only about $100-$200 more per month than compound if on a dose <=10mg.
Still super expensive compared to gray but for many this could be an option. With insurance my Zepbound co-pay is just over $200 (for any dose) so $500 without insurance isn't as crazy as it sounds, especially if you don't have access to, or don't want to go gray.
Last edited: